Table 1 Cohort-1 test-retest patient characteristics
|  |  | Bone | Breast |  |  | 18F-FDG Scan Differences§ |  | ||
|---|---|---|---|---|---|---|---|---|---|
|  |  | Lesions | Cancer | ER/PR/Her2†| Treatment | ∆Days | ∆UT | ∆%Dose | ∆[Glc] |
Case | Age | (n) | Type* | Status | Therapy‡ | (days) | (min) | (%) | (mg/dL) |
01 | 51 | 9 | IDC | +/+/+ | Horm/HDT | 14 | 3.0 | -13% | 5.0 |
02 | 55 | 2 | IDC | +/+/= | Chemo | 8 | 1.0 | 0% | -14.3 |
03 | 60 | 9 | IDC | -/-/+ | Chemo/HDT | 8 | 0.0 | -7% | 1.0 |
05 | 38 | 1 | IDC | +/+/= | Not Started | 2 | 0.0 | 2% | -14.0 |
06 | 62 | 7 | Mixed | +/+/- | Chemo | 7 | 0.0 | 3% | -3.7 |
07 | 52 | 3 | IDC | +/+/- | Horm | 14 | 0.0 | -3% | -6.7 |
18 | 67 | 3 | DCIS | +/-/- | Not Started | 12 | 6.0 | -6% | 19.0 |
24 | 32 | 4 | Unk | +/-/+ | Horm/HDT | 8 | 3.0 | 1% | 7.0 |
26 | 57 | 1 | IDC | +/+/- | Horm | 7 | -4.0 | -16% | 4.0 |
Mean | 51 | 5 | - | - | - | 9 | 1.0 | -4% | -0.3 |
SD | 11 | 3 | - | - | - | 4 | 2.8 | 7% | 10.7 |